We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In a reversal for the agency, the FDA called for the immediate withdrawal of all ranitidine products from the U.S. market due to N-Nitrosodimethylamine (NDMA) contamination. Read More
A coalition of more than 50 rheumatology and lupus organizations urged all 50 governors in a letter to ensure patient access to chloroquine and hydroxychloroquine, which are used to treat lupus and arthritis, as well as malaria and now COVID-19. Read More
A group representing the drug supply chain is strongly arguing that a proposed executive order to only supply drugs domestically could mean that Americans won’t have access to the drugs they need. Read More
A federal court has invalidated six key patents for Amarin’s potential blockbuster heart drug Vascepa, opening the door for generic competitors. Read More
Manufacturers need to provide two-week updates on any supply issues during the COVID-19 emergency and going forward, the FDA said in a new straight-to-final guidance. Read More